Citation: J. Howes et Gd. Novack, FAILURE TO DETECT SYSTEMIC LEVELS, AND EFFECTS OF LOTEPREDNOL ETABONATE AND ITS METABOLITE, PJ-91, FOLLOWING CHRONIC OCULAR ADMINISTRATION, Journal of ocular pharmacology and therapeutics, 14(2), 1998, pp. 153-158
Citation: Gd. Novack et al., CHANGE IN INTRAOCULAR-PRESSURE DURING LONG-TERM USE OF LOTEPREDNOL ETABONATE, Journal of glaucoma, 7(4), 1998, pp. 266-269
Authors:
STEWART R
HORWITZ B
HOWES J
NOVACK GD
HART K
Citation: R. Stewart et al., DOUBLE-MASKED, PLACEBO-CONTROLLED EVALUATION OF LOTEPREDNOL ETABONATE0.5-PERCENT FOR POSTOPERATIVE INFLAMMATION, Journal of cataract and refractive surgery, 24(11), 1998, pp. 1480-1489
Authors:
BEEHLER C
BODNER B
BOWMAN B
COOKE D
CRABB JL
DEBARGE LR
DONNENFELD E
ESTOPINAL M
FOX K
KASTL P
OLANDER K
SHARPE E
SHOFNER R
STAHL J
STEVENSON D
STEWART W
WALTERS T
GILL S
HOWES J
LAWSON C
SMERICK M
ZACCARDELLI D
FAZIO R
NOVACK GD
CROCKETT RS
HART K
Citation: C. Beehler et al., A DOUBLE-MASKED, PLACEBO-CONTROLLED EVALUATION OF 0.5-PERCENT LOTEPREDNOL ETABONATE IN THE TREATMENT OF POSTOPERATIVE INFLAMMATION, Ophthalmology (Rochester, Minn.), 105(9), 1998, pp. 1780-1786
Authors:
DELL SJ
LOWRY GM
NORTHCUTT JA
HOWES J
NOVACK GD
HART K
Citation: Sj. Dell et al., A RANDOMIZED, DOUBLE-MASKED, PLACEBO-CONTROLLED PARALLEL STUDY OF 0.2-PERCENT LOTEPREDNOL ETABONATE IN PATIENTS WITH SEASONAL ALLERGIC CONJUNCTIVITIS, Journal of allergy and clinical immunology, 102(2), 1998, pp. 251-255
Citation: Jc. Cloyd et al., A SINGLE-BLIND, CROSSOVER COMPARISON OF THE PHARMACOKINETICS AND COGNITIVE EFFECTS OF A NEW DIAZEPAM RECTAL GEL WITH INTRAVENOUS DIAZEPAM, Epilepsia, 39(5), 1998, pp. 520-526
Citation: Gd. Novack, REGULATORY REVIEW INTERVALS FOR OPHTHALMIC NEW DRUG APPLICATIONS AT THE US FOOD-AND-DRUG-ADMINISTRATION, American journal of ophthalmology, 126(1), 1998, pp. 122-126
Citation: Js. Cohen et al., THE ROLE OF MITOMYCIN TREATMENT DURATION AND PREVIOUS INTRAOCULAR SURGERY ON THE SUCCESS OF TRABECULECTOMY SURGERY, Journal of glaucoma, 6(1), 1997, pp. 3-9
Citation: Gd. Novack, REVIEW TIMES FOR OPHTHALMIC NEW DRUG APPLICATIONS (NDAS) AT THE US FOOD-AND-DRUG-ADMINISTRATION (FDA), Investigative ophthalmology & visual science, 38(4), 1997, pp. 1346-1346
Authors:
DELL SJ
SHULMAN DG
LOWRY GM
HOWES J
BERDY G
EMBRY S
FOX K
HORWITZ B
KUNESHPART K
LAIBOVITZ R
LEVIN J
LOWRY G
ORLANDO R
PARKS D
WALTERS T
COULTAS S
HART K
CROCKETT RS
NOVACK GD
Citation: Sj. Dell et al., A CONTROLLED EVALUATION OF THE EFFICACY AND SAFETY OF LOTEPREDNOL ETABONATE IN THE PROPHYLACTIC TREATMENT OF SEASONAL ALLERGIC CONJUNCTIVITIS, American journal of ophthalmology, 123(6), 1997, pp. 791-797
Citation: Js. Cohen et al., A PLACEBO-CONTROLLED, DOUBLE-MASKED EVALUATION OF MITOMYCIN-C IN COMBINED GLAUCOMA AND CATARACT PROCEDURES, Ophthalmology, 103(11), 1996, pp. 1934-1942
Citation: Gd. Novack, EXCESSIVE BETA-BLOCKADE WITH TIMOLOL EYE DROPS, JAMA, the journal of the American Medical Association, 275(13), 1996, pp. 985-985
Citation: Gd. Novack et J. Howes, FAILURE TO DETECT SYSTEMIC LEVELS, AND EFFECTS OF LOTEPREDNOL ETABONATE AND ITS METABOLITE PJ-91 FOLLOWING CHRONIC OCULAR ADMINISTRATION, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 59-59
Citation: Gd. Novack et Al. Robin, RANDOMIZED CLINICAL-TRIALS ON MEDICAL-TREATMENT OF GLAUCOMA - ARE THEY APPROPRIATE TO GUIDE CLINICAL-PRACTICE, Archives of ophthalmology, 112(6), 1994, pp. 726-726
Authors:
BLAYDES JE
KELLEY EP
WALT JG
DEGRYSE RE
HARPER DG
NOVACK GD
Citation: Je. Blaydes et al., FLURBIPROFEN 0.03-PERCENT FOR THE CONTROL OF INFLAMMATION FOLLOWING CATARACT-EXTRACTION BY PHACOEMULSIFICATION, Journal of cataract and refractive surgery, 19(4), 1993, pp. 481-487